Avandia and Heart Attacks

connection between avandia and prompts fda safety alert

avandia diabetes insulinAs many as 100,000 may be linked to , according to Sen. Charles Grassley (R-Iowa) in a floor statement placed in the Senate record on May 24, 2007.

, sold by the British company PLC, is a blockbuster medication used to treat , the most common form of the disease. More than 6 million people worldwide have taken the drug, whose U.S. sales topped $2.2 billion last year.

Analysis led by Cleveland Clinic cardiology chief Dr. Steven Nissen of 42 separate studies on concluded that it raised the risk of by 43 percent, compared to the rates among people taking no or other diabetes drugs. The analysis also indicated that might increase the risk of heart-related deaths.

Any increase in risk is especially worrisome for diabetics because two-thirds of them die of heart problems.

About 1 million Americans are currently taking , which costs from $90 to $170 for a one-month supply.

The FDA and diabetes experts are advising users of to talk to their doctors and not to immediately discontinue the drug.

Learn more about Avandia side effects.

free legal consultation

If you or a loved one have suffered serious side effects while taking , if you have been diagnosed with blood clots, , or stroke, or if you are experiencing the symptoms associated with any of these serious side effects, you may have a claim against the manufacturer of .

Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.

Latest News

FDA to remove Avandia from retail pharmacies

fda logo 100x100The diabetes drug Avandia will no longer be sold at retail pharmacies beginning in November because of the serious health risks it poses to patients. The Food and Drug Administration (FDA) voted to severely restrict use of and related drugs last fall after studies showed that users with who took the drug were at a 40 percent increased risk of . Beginning in November, patients will only be able to get the drug by mail order from certified pharmacies participating in a special agency-supported program.

Read the rest of this entry »

FDA approves new warnings on Avandia packaging

images2 100x100New warnings for the drug rosiglitazone, better known by the brand name Avandia, has been approved by the Food and Drug Administration (FDA). The warnings, including a black box warning, will be immediately added to the safety labeling and packaging for (rosiglitazone maleate), as well as other drugs with the same active ingredient, including Avandament (rosiglitazone maleate/metformin hydrochloride), and Avandaryl (rosiglitazone maleate/glimepride).

Read the rest of this entry »

GSK pays out more money to settle lawsuits against deadly diabetes drug

(GSK) has agreed to pay more than $250 million to resolve about 5,500 claims that its drug Avandia (rosiglitazone) caused and strokes in patients who used the drug. The payout will help GSK avoid the first trial over claims the pharmaceutical giant allowed the drug to be marketed despite reports that the drug was potentially deadly.

Read the rest of this entry »